1998
DOI: 10.1016/s0926-9959(98)95695-1
|View full text |Cite
|
Sign up to set email alerts
|

Psoriasis, its treatment and cancer in a cohort of Finnish patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
84
3
1

Year Published

2001
2001
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(92 citation statements)
references
References 0 publications
4
84
3
1
Order By: Relevance
“…This is particularly relevant in patients with psoriasis, as an association with internal cancer has been found in large cohort studies, 306,307 which includes oral tumours and tumours of the pharynx, lung, liver, pancreas, liver and bladder, and lymphoma. [308][309][310] However, previous studies have not demonstrated a consistent increase in cancer risk in the central nervous system, thyroid gland, respiratory system, pancreas or kidney. 264,281,311 Although there are several case reports of leukaemia developing during PUVA therapy, [312][313][314][315] Stern and Lange and Stern et al reported no increase in lymphoma or leukaemia in a PUVA cohort, in either 1988 or 1997; 263,279 however, more recent analysis has found the incidence of lymphoma to be increased in this group in those exposed to high levels of MTX (RR 4Á39), that is, 36 months of treatment or longer, but not in those exposed to low levels.…”
Section: Psoralen-ultraviolet a Therapy-induced Skin Cancermentioning
confidence: 99%
See 1 more Smart Citation
“…This is particularly relevant in patients with psoriasis, as an association with internal cancer has been found in large cohort studies, 306,307 which includes oral tumours and tumours of the pharynx, lung, liver, pancreas, liver and bladder, and lymphoma. [308][309][310] However, previous studies have not demonstrated a consistent increase in cancer risk in the central nervous system, thyroid gland, respiratory system, pancreas or kidney. 264,281,311 Although there are several case reports of leukaemia developing during PUVA therapy, [312][313][314][315] Stern and Lange and Stern et al reported no increase in lymphoma or leukaemia in a PUVA cohort, in either 1988 or 1997; 263,279 however, more recent analysis has found the incidence of lymphoma to be increased in this group in those exposed to high levels of MTX (RR 4Á39), that is, 36 months of treatment or longer, but not in those exposed to low levels.…”
Section: Psoralen-ultraviolet a Therapy-induced Skin Cancermentioning
confidence: 99%
“…316 A study from Finland showed a 2Á2-fold increase in non-Hodgkin lymphoma in patients hospitalized for psoriasis. 309 Noncancerous chronic cutaneous side-effects of psoralen-ultraviolet A therapy Keratoses are typically localized to nonsun-exposed skin; risk factors for their development include increased age, male sex and high cumulative UVA dose. 288 They are reported to occur in 46% of patients receiving high-dose (> 2000 J cm À2 ) PUVA and show cytological atypia.…”
Section: Psoralen-ultraviolet a Therapy-induced Skin Cancermentioning
confidence: 99%
“…results from other studies [19,20] documented the negative effects of substances of abuse on the course of psoriasis, as well as the outcome of treatment. cigarette smoking and unhealthy eating habits may pose a risk of other conditions, including cancers that are more common among psoriasis patients than in the general population [21,22]. it is also important that the mean Bmi in psoriasis patients is above the normal range.…”
Section: Key Resultsmentioning
confidence: 99%
“…Also, several cohort and case-control studies led to conclusion that PUVA therapy can cause squamous cell skin cancer in a dose-and time-dependent manner (15). For example, in a study of Hannuksela-Svahn et al (16), the number of patients needed to be treated with PUVA to result in one extra case of this type of skin cancer was 3030. Therefore, the Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency (EMA) issued the document on the risks associated with FCs contained in preparations of angelica, Angelica archangelica L. (Apiaceae), in which maximum daily intake of FCs through herbal medicinal products is given.…”
Section: Introductionmentioning
confidence: 99%